title: [Treatment of allergic rhinitis: update 2005].
abstract: Potential approaches to the treatment of allergic rhinitis are the avoidance of allergens and medication with chromone compounds, antihistaminics and glucocorticosteroids. The sole causally effective treatment is specific immunotherapy. Leukotriene receptor antagonists, anti-IgE antibodies and monoclonal CD-4-molecules, as also soluble cytokine receptors are potential therapeutic options, the value of which currently remains unknown.
authors.affiliation: HNO-Praxis, Starnberg. grevers@gmx.de
authors.forename: G
authors.initials: G
authors.lastname: Grevers
mesh_terms: D000284:Administration, Oral; D000287:Administration, Topical; D000328:Adult; D000485:Allergens; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001249:Asthma / Q000150:complications; D002648:Child; D002867:Chromones / Q000008:administration & dosage / Q000627:therapeutic use; D003233:Conjunctivitis, Allergic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D018849:Controlled Clinical Trials as Topic; D005938:Glucocorticoids / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D020024:Leukotriene Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D018121:Receptors, Cytokine / Q000008:administration & dosage / Q000627:therapeutic use; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*
chemical_list: D000485:Allergens; D018927:Anti-Asthmatic Agents; D002867:Chromones; D005938:Glucocorticoids; D006633:Histamine Antagonists; D020024:Leukotriene Antagonists; D018121:Receptors, Cytokine